Header Logo

Connection

Frederick Raal to Hypolipidemic Agents

This is a "connection" page, showing publications Frederick Raal has written about Hypolipidemic Agents.
Connection Strength

2,148
  1. PCSK9 Inhibitors: From Nature's Lessons to Clinical Utility. Endocr Metab Immune Disord Drug Targets. 2020; 20(6):840-854.
    View in: PubMed
    Score: 0,683
  2. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics. Cardiovasc J Afr. 2015 Jul-Aug; 26(4):188-92.
    View in: PubMed
    Score: 0,500
  3. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord. 2009 Apr; 7(2):83-8.
    View in: PubMed
    Score: 0,324
  4. Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials. Cardiovasc Drugs Ther. 2024 Jun; 38(3):493-503.
    View in: PubMed
    Score: 0,210
  5. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects. Atherosclerosis. 1997 Feb 28; 129(1):97-102.
    View in: PubMed
    Score: 0,140
  6. Suboptimal Control of Lipid Levels: Results from 29 Countries Participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). J Atheroscler Thromb. 2016 May 02; 23(5):567-87.
    View in: PubMed
    Score: 0,129
  7. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG). Cardiovasc J Afr. 2008 Mar-Apr; 19(2):88-94.
    View in: PubMed
    Score: 0,075
  8. Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis? Clin Endocrinol (Oxf). 1997 Mar; 46(3):365-8.
    View in: PubMed
    Score: 0,035
  9. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015 May 01; 36(17):1012-22.
    View in: PubMed
    Score: 0,030
  10. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated? Cardiovasc J Afr. 2010 May-Jun; 21(3 Suppl):S9-S13.
    View in: PubMed
    Score: 0,022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.